Ironwood Pharmaceuticals, Inc. (IRWD)
USD 3.46
(-1.98%)
USD 3.46
(-1.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 442.73 Million | 410.59 Million | 413.75 Million | 389.52 Million | 428.41 Million | 346.63 Million |
| Cost of Revenue | 1.57 Million | 1.41 Million | 1.52 Million | 3.13 Million | 23.87 Million | 32.75 Million |
| Gross Profit | 441.16 Million | 409.17 Million | 412.23 Million | 386.38 Million | 404.53 Million | 313.88 Million |
| Operating Expenses | 232.12 Million | 160.25 Million | 181.53 Million | 228.06 Million | 287.49 Million | 415.9 Million |
| Selling, General and Administrative Expenses | 158.31 Million | 115.99 Million | 111.13 Million | 140 Million | 172.45 Million | 241.29 Million |
| Research and Development Expenses | 116.08 Million | 44.26 Million | 70.4 Million | 88.06 Million | 115.04 Million | 166.5 Million |
| Other Expenses | - | - | - | 24 Thousand | 514 Thousand | 8.11 Million |
| Cost and Expenses | 233.69 Million | 160.25 Million | 181.53 Million | 231.2 Million | 311.36 Million | 448.65 Million |
| Operating Income | 209.03 Million | 250.33 Million | 232.25 Million | 142.94 Million | 120.12 Million | -238.89 Million |
| Interest Expense | 21.62 Million | 7.59 Million | 31.15 Million | 29.47 Million | 36.6 Million | 34.73 Million |
| Income Tax Expense | 83.49 Million | 77.35 Million | -327.79 Million | 2.68 Million | 74.25 Million | -5.75 Million |
| Earnings before Tax | -948.06 Million | 252.42 Million | 200.65 Million | 108.86 Million | 58.94 Million | -282.36 Million |
| Net Income | -1 Billion | 175.06 Million | 528.44 Million | 106.17 Million | -15.31 Million | -282.36 Million |
| Earnings Per Share Basic | -6.45 | 1.13 | 3.26 | 0.67 | -0.10 | -1.85 |
| Earnings Per Share Diluted | -6.45 | 0.94 | 3.21 | 0.66 | -0.10 | -1.85 |
| Weighted Average Shares Outstanding | 155.43 Million | 154.36 Million | 162.24 Million | 159.42 Million | 156.02 Million | 152.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 155.43 Million | 186.31 Million | 164.41 Million | 160.65 Million | 156.02 Million | 152.63 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 0.99 | 0.94 | 0.91 |
| EBIT Margin | -2.09 | 0.63 | 0.56 | 0.41 | 0.28 | -0.27 |
| Profit Margin | -2.26 | 0.43 | 1.28 | 0.27 | -0.04 | -0.81 |
| EBITDA | -924.86 Million | 261.43 Million | 233.33 Million | 141.9 Million | 101.12 Million | -144.45 Million |
| Earnings Before Tax Margin | 0.47 | 0.61 | 0.56 | 0.37 | 0.28 | -0.69 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 94.39 Million | 74.87 Million | 117.55 Million | 442.73 Million | 113.73 Million | 107.38 Million |
| Cost of Revenue | 506 Thousand | 513 Thousand | 512 Thousand | 1.57 Million | 507 Thousand | 270 Thousand |
| Gross Profit | 93.89 Million | 74.36 Million | 117.04 Million | 441.16 Million | 113.23 Million | 107.11 Million |
| Operating Expenses | 66.84 Million | 62.9 Million | 72.63 Million | 232.12 Million | 69.03 Million | 1.17 Billion |
| Selling, General and Administrative Expenses | 36.96 Million | 37.6 Million | 37.56 Million | - | 36.04 Million | 52.48 Million |
| Research and Development Expenses | 29.88 Million | 25.3 Million | 35.06 Million | - | 32.98 Million | 1.12 Billion |
| Other Expenses | - | - | 5.62 Million | - | - | - |
| Cost and Expenses | 67.35 Million | 63.42 Million | 73.14 Million | 233.69 Million | 69.03 Million | 1.17 Billion |
| Operating Income | 27.04 Million | 11.45 Million | 44.41 Million | 209.03 Million | 40.02 Million | -1.08 Billion |
| Interest Expense | 7.47 Million | 6.82 Million | 8.42 Million | 21.62 Million | 9.83 Million | 1.84 Million |
| Income Tax Expense | 19.73 Million | 9.12 Million | 32.1 Million | 83.49 Million | 17.98 Million | 13.25 Million |
| Earnings before Tax | 18.87 Million | 4.95 Million | 30.36 Million | -948.06 Million | 31.93 Million | -1.07 Billion |
| Net Income | -860 Thousand | -4.16 Million | -1.08 Million | -1 Billion | 15.32 Million | -1.06 Billion |
| Earnings Per Share Basic | -0.01 | -0.03 | -0.01 | - | 0.10 | -6.84 |
| Earnings Per Share Diluted | -0.01 | -0.03 | -0.01 | - | 0.08 | -6.84 |
| Weighted Average Shares Outstanding | 159.01 Million | 157.7 Million | 156.01 Million | 155.43 Million | 155.88 Million | 155.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 159.01 Million | 157.7 Million | 156.01 Million | 155.43 Million | 186.89 Million | 155.36 Million |
| Gross Margin | 0.99 | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 0.29 | 0.16 | 0.38 | - | 0.41 | -9.88 |
| Profit Margin | -0.01 | -0.06 | -0.01 | -2.26 | 0.13 | -9.89 |
| EBITDA | 27.55 Million | 11.97 Million | 44.92 Million | - | 46.45 Million | -1.06 Billion |
| Earnings Before Tax Margin | 0.29 | 0.15 | 0.38 | 0.47 | 0.35 | -10.09 |
024070
UNTN
1304
KDSI
0J4V
5126